Article info
PDFOriginal research
Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method
- Correspondence to Dr. Friederike Liesche-Starnecker, Department of Neuropathology, Institute of Pathology, Technical University Munich, School of Medicine, Munich, Germany; friederike.liesche{at}tum.de
Citation
Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method
Publication history
- Received July 16, 2019
- Revised July 29, 2019
- Accepted July 30, 2019
- First published August 17, 2019.
Online issue publication
August 11, 2020
Article Versions
- Previous version (21 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.